Best Diagnostic & Research Stocks to Buy Now (2024)Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.
Industry: Diagnostics & Research
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | NASDAQ | Diagnostics & Research | $26.02B | $314.72 | -0.35% | $1.62B | 37.92x | 0.81 | |
| STRR | STAR EQUITY HOLDINGS INC | NASDAQ | Diagnostics & Research | $13.95M | $0.88 | -1.12% | $26.87M | 0.55x | 0.16 | |
| FONR | FONAR CORP | NASDAQ | Diagnostics & Research | $102.27M | $15.24 | -2.99% | $25.65M | 9.47x | 0.32 | |
| TMO | THERMO FISHER SCIENTIFIC INC | NYSE | Diagnostics & Research | $227.24B | $595.30 | -0.31% | $11.37B | 38.04x | 1.13 | |
| IDXX | IDEXX LABORATORIES INC | NASDAQ | Diagnostics & Research | $44.88B | $543.45 | 0.46% | $1.24B | 52.10x | 1.14 | |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | NYSE | Diagnostics & Research | $11.42B | $221.61 | -1.40% | $1.00B | 25.92x | 1.22 | |
| ENZ | ENZO BIOCHEM INC | NYSE | Diagnostics & Research | $55.84M | $1.09 | -1.80% | $33.74M | 1.63x | 0.40 | |
| DGX | QUEST DIAGNOSTICS INC | NYSE | Diagnostics & Research | $16.03B | $144.34 | 1.34% | $1.70B | 19.17x | 1.16 | |
| MEDP | MEDPACE HOLDINGS INC | NASDAQ | Diagnostics & Research | $12.19B | $393.30 | 0.01% | $405.89M | 38.67x | 1.67 | |
| SHC | SOTERA HEALTH CO | NASDAQ | Diagnostics & Research | $3.20B | $11.29 | -1.05% | $426.24M | 59.42x | 6.13 | |
| NEOG | NEOGEN CORP | NASDAQ | Diagnostics & Research | $2.93B | $13.54 | 0.97% | $188.76M | 677.00x | 0.46 | |
| LAB | STANDARD BIOTOOLS INC | NASDAQ | Diagnostics & Research | $956.40M | $2.57 | 2.80% | -$76.45M | -2.54x | 0.35 | |
| A | AGILENT TECHNOLOGIES INC | NYSE | Diagnostics & Research | $45.20B | $154.23 | -0.05% | $1.69B | 36.55x | 0.77 | |
| QGEN | QIAGEN NV | NYSE | Diagnostics & Research | $10.23B | $45.69 | -0.65% | $680.17M | 31.12x | 0.61 | |
| DHR | DANAHER CORP | NYSE | Diagnostics & Research | $196.87B | $265.80 | 0.36% | $7.54B | 44.60x | 0.56 | |
| FLGT | FULGENT GENETICS INC | NASDAQ | Diagnostics & Research | $661.63M | $22.11 | -1.73% | -$127.63M | -3.97x | 0.09 | |
| SERA | SERA PROGNOSTICS INC | NASDAQ | Diagnostics & Research | $269.72M | $8.26 | -1.43% | -$32.31M | -7.72x | 0.39 | |
| CSTL | CASTLE BIOSCIENCES INC | NASDAQ | Diagnostics & Research | $669.20M | $24.24 | 0.08% | -$17.87M | -21.26x | 0.14 | |
| EXAS | EXACT SCIENCES CORP | NASDAQ | Diagnostics & Research | $9.30B | $50.38 | -3.02% | $32.77M | -38.17x | 1.04 | |
| NTRA | NATERA INC | NASDAQ | Diagnostics & Research | $13.07B | $106.46 | -1.88% | -$311.83M | -34.12x | 0.85 | |
| PRE | PRENETICS GLOBAL LTD | NASDAQ | Diagnostics & Research | $70.84M | $5.80 | -0.79% | -$55.20M | -1.04x | 0.21 | |
| RVTY | REVVITY INC | NYSE | Diagnostics & Research | $13.60B | $110.23 | 1.63% | $665.40M | 90.35x | 0.71 | |
| CHEK | CHECK-CAP LTD | NASDAQ | Diagnostics & Research | $12.78M | $2.19 | -2.37% | -$19.08M | -0.73x | 0.06 | |
| OLK | OLINK HOLDING AB (PUBL) | NASDAQ | Diagnostics & Research | $2.98B | $23.95 | 0.00% | -$21.35M | -88.70x | 0.18 | |
| LH | LABCORP HOLDINGS INC | NYSE | Diagnostics & Research | $17.75B | $210.59 | -1.19% | $1.55B | 41.29x | 1.08 | |
| WAT | WATERS CORP | NYSE | Diagnostics & Research | $21.11B | $355.95 | -1.26% | $979.13M | 34.86x | 2.59 | |
| PRPO | PRECIPIO INC | NASDAQ | Diagnostics & Research | $9.24M | $6.29 | 1.29% | -$3.37M | -1.84x | 0.30 | |
| DRIO | DARIOHEALTH CORP | NASDAQ | Diagnostics & Research | $56.85M | $1.90 | 1.06% | -$50.61M | -1.13x | 0.76 | |
| NEO | NEOGENOMICS INC | NASDAQ | Diagnostics & Research | $1.89B | $14.80 | -1.27% | $1.33M | -22.42x | 0.78 | |
| TWST | TWIST BIOSCIENCE CORP | NASDAQ | Diagnostics & Research | $2.74B | $47.01 | 1.10% | -$155.32M | -13.99x | 0.26 | |
| IQV | IQVIA HOLDINGS INC | NYSE | Diagnostics & Research | $42.12B | $231.18 | -1.63% | $3.27B | 31.16x | 3.19 | |
| MTD | METTLER TOLEDO INTERNATIONAL INC | NYSE | Diagnostics & Research | $32.52B | $1,522.75 | -0.51% | $1.17B | 42.48x | -21.69 | |
| BNR | BURNING ROCK BIOTECH LTD | NASDAQ | Diagnostics & Research | $85.03M | $8.30 | 3.36% | -$71.63M | -0.94x | 0.35 | |
| ACRS | ACLARIS THERAPEUTICS INC | NASDAQ | Diagnostics & Research | $84.81M | $1.19 | 0.85% | -$76.72M | -1.09x | 0.23 | |
| RDNT | RADNET INC | NASDAQ | Diagnostics & Research | $4.24B | $57.45 | -0.23% | $281.33M | 174.09x | 2.17 | |
| CDNA | CAREDX INC | NASDAQ | Diagnostics & Research | $807.30M | $15.50 | 4.87% | -$175.06M | -4.55x | 0.77 | |
| PSNL | PERSONALIS INC | NASDAQ | Diagnostics & Research | $72.71M | $1.40 | 0.36% | -$79.45M | -0.74x | 0.62 | |
| STIM | NEURONETICS INC | NASDAQ | Diagnostics & Research | $78.29M | $2.61 | 3.57% | -$19.49M | -2.75x | 2.75 | |
| ME | 23ANDME HOLDING CO | NASDAQ | Diagnostics & Research | $283.47M | $0.59 | -1.68% | -$490.64M | -0.53x | 0.61 | |
| GH | GUARDANT HEALTH INC | NASDAQ | Diagnostics & Research | $3.10B | $25.36 | -3.35% | -$414.22M | -6.40x | 23.96 | |
| XWEL | XWELL INC | NASDAQ | Diagnostics & Research | $7.28M | $1.74 | -3.60% | -$21.66M | -0.29x | 1.77 | |
| OCX | ONCOCYTE CORP | NASDAQ | Diagnostics & Research | $39.16M | $2.93 | -4.56% | -$38.55M | -0.58x | 4.67 | |
| MYGN | MYRIAD GENETICS INC | NASDAQ | Diagnostics & Research | $2.29B | $25.29 | 2.76% | -$163.70M | -9.03x | 0.46 | |
| DMTK | DERMTECH INC | NASDAQ | Diagnostics & Research | $17.45M | $0.50 | -12.61% | -$84.05M | -0.19x | 1.58 | |
| XGN | EXAGEN INC | NASDAQ | Diagnostics & Research | $32.66M | $1.88 | -0.53% | -$14.09M | -1.72x | 1.54 | |
| PRPH | PROPHASE LABS INC | NASDAQ | Diagnostics & Research | $95.97M | $5.03 | -1.57% | -$23.50M | -3.70x | 1.01 | |
| AWH | ASPIRA WOMEN's HEALTH INC | NASDAQ | Diagnostics & Research | $33.12M | $2.66 | 0.76% | -$14.60M | -1.87x | -6.26 | |
| NDRA | ENDRA LIFE SCIENCES INC | NASDAQ | Diagnostics & Research | $3.39M | $0.31 | 8.87% | -$9.63M | -0.27x | 0.37 | |
| VNRX | VOLITIONRX LTD | NYSEMKT | Diagnostics & Research | $63.77M | $0.77 | -3.75% | -$33.26M | -1.67x | -2.31 | |
| MDXH | MDXHEALTH SA | NASDAQ | Diagnostics & Research | $7.86M | $2.88 | 0.70% | -$21.40M | -0.21x | -126.12 | |
| GENE | GENETIC TECHNOLOGIES LTD | NASDAQ | Diagnostics & Research | $526.30k | $2.28 | -0.44% | N/A | -0.77x | 0.76 | |
| NOTV | INOTIV INC | NASDAQ | Diagnostics & Research | $50.12M | $1.93 | -9.81% | $19.33M | -0.70x | 2.94 | |
| BIAF | BIOAFFINITY TECHNOLOGIES INC | NASDAQ | Diagnostics & Research | $26.35M | $2.26 | -7.76% | -$7.92M | -2.46x | 0.53 | |
| MYNZ | MAINZ BIOMED NV | NASDAQ | Diagnostics & Research | $14.39M | $0.68 | 5.92% | -$24.62M | -0.42x | 3.74 | |
| ILMN | ILLUMINA INC | NASDAQ | Diagnostics & Research | $17.69B | $111.07 | -2.96% | -$640.00M | -13.63x | 0.75 | |
| OPK | OPKO HEALTH INC | NASDAQ | Diagnostics & Research | $920.03M | $1.32 | 1.54% | -$128.11M | -3.77x | 0.58 | |
| PMD | PSYCHEMEDICS CORP | NASDAQ | Diagnostics & Research | $14.98M | $2.58 | 0.78% | -$970.00k | -3.35x | 0.78 | |
| APDN | APPLIED DNA SCIENCES INC | NASDAQ | Diagnostics & Research | $2.47M | $2.51 | -8.73% | -$11.10M | -0.15x | -194.21 | |
| TRIB | TRINITY BIOTECH PLC | NASDAQ | Diagnostics & Research | $12.11M | $1.58 | 0.64% | -$11.25M | -0.49x | -3.48 | |
| BDSX | BIODESIX INC | NASDAQ | Diagnostics & Research | $180.63M | $1.58 | 0.96% | -$32.10M | -2.92x | -16.85 | |
| MMA | ALTA GLOBAL GROUP LTD | NYSEMKT | Diagnostics & Research | N/A | $4.54 | 3.74% | -$16.12M | -0.86x | -0.55 | |
| ISPC | ISPECIMEN INC | NASDAQ | Diagnostics & Research | $2.40M | $0.24 | -3.98% | -$9.41M | -0.19x | 0.84 | |
| TTOO | T2 BIOSYSTEMS INC | NASDAQ | Diagnostics & Research | $49.59M | $5.64 | 0.00% | -$38.59M | -0.49x | -1.66 | |
| CNTG | CENTOGENE NV | NASDAQ | Diagnostics & Research | $10.21M | $0.37 | -2.63% | -$20.95M | -0.27x | -4.05 |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.